Hyponatremia in patients with schizophrenia

Area of Science:

• Psychiatry
• Nephrology
• Clinical Medicine

Background:

• Hyponatremia, a condition of low serum sodium, is associated with schizophrenia but its incidence and causes remain unclear.
• Understanding this association is crucial for patient management and preventing severe complications.

Purpose of the Study:

• To determine the incidence of hyponatremia in schizophrenia patients.
• To identify risk factors and clinical features associated with hyponatremia in this population.

Main Methods:

• Retrospective study of hospital admissions over 3.5 years.
• Comparison of hyponatremic schizophrenia patients with non-hyponatremic schizophrenia patients.
• Analysis of medication use and water intake patterns.

Main Results:

• Incidence of hyponatremia was 5.8% in schizophrenia patients versus 0.36% in all admissions (P < .01).
• Excessive water intake (P < .01) and use of thioxanthene antipsychotics (P = .05) and anticholinergic medications (P < .01) were significant risk factors.
• Patients with hyponatremia often presented with severe neurologic dysfunction and dangerously low serum sodium levels (≤120 mEq/L).

Conclusions:

• Schizophrenia patients have a significantly higher incidence of hyponatremia.
• Excessive water intake and specific medication classes are associated with hyponatremia in schizophrenia.
• The role of antidiuretic hormone in this context warrants further investigation.